Literature DB >> 8566867

Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease.

N Mahmud1, G S McDonald, D Kelleher, D G Weir.   

Abstract

It has previously been shown that microalbuminuria is a useful disease activity marker for inflammatory bowel disease (IBD). Microalbuminuria correlates strongly with the markers of clinical and laboratory disease activity such as erythrocyte sedimentation rate (ESR), and C reactive protein (CRP). The aim of this study was to discover if microalbuminuria accurately reflects the intestinal inflammation by correlating it with intestinal inflammation using a standard histopathological grading system in patients with ulcerative colitis and Crohn's colitis. Forty two patients with IBD who had undergone endoscopic examination of the entire colon for the assessment of severity and extent of the disease (Crohn's colitis (n = 21), ulcerative colitis (n = 21)) were recruited to the study. Patients with small bowel Crohn's disease were not studied. Twenty four patients had left sided colonic disease and 18 patients had extensive colonic disease. Each patient's colonic biopsy specimens were scored blindly by a histopathologist and a composite score was compiled on the basis of the severity of changes in the enterocytes and crypts and the cellularity of the lamina propria. A clinical disease activity was obtained using the simple index of Harvey and Bradshaw. Microalbuminuria was measured in all patients by an immunoturbiditimetric method. ESR and CRP were also measured, as indicators of acute phase response in the same patients. It was found that patients with active IBD had higher concentrations of microalbuminuria compared with those patients in remission (median 222 micrograms/min (range 40-686 micrograms/min) v median 96 micrograms/min (range 30-376 micrograms/min); p < 0.001)). Significantly higher concentrations of microalbuminuria were also detected in patients with extensive colonic IBD compared with those patients with left sided disease (median 297 micrograms/min (range 132-686 micrograms/min) v median 101 micrograms/min (range 30-433 micrograms/min); p < 0.001)). A strong positive correlation was seen between microalbuminuria and intestinal histopathological score in IBD patient groups with left sided colitis (r = 0.77; p < 0.001) and extensive disease (r = 0.71; p < 0.01). The standard histopathological grading system correlated with the clinical disease activity (r = 0.64; p < 0.005) and CRP (r = 0.62; p < 0.02), however, it did not correlate with ESR. In conclusion, the strong correlation of microalbuminuria with a standard intestinal histopathological grading system suggests that microalbuminuria accurately reflects the severity of colonic inflammation in patients with Crohn's colitis and ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8566867      PMCID: PMC1382986          DOI: 10.1136/gut.38.1.99

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  Intestinal protein loss in Crohn's disease.

Authors:  W L Beeken; H J Busch; D L Sylwester
Journal:  Gastroenterology       Date:  1972-02       Impact factor: 22.682

Review 2.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

3.  A simple index of Crohn's-disease activity.

Authors:  R F Harvey; J M Bradshaw
Journal:  Lancet       Date:  1980-03-08       Impact factor: 79.321

4.  Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn's disease.

Authors:  S H Saverymuttu; A M Peters; J P Lavender; M B Pepys; H J Hodgson; V S Chadwick
Journal:  Gastroenterology       Date:  1983-12       Impact factor: 22.682

5.  Removal of sulfated (heparan sulfate) or nonsulfated (hyaluronic acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to 125I-bovine serum albumin.

Authors:  L J Rosenzweig; Y S Kanwar
Journal:  Lab Invest       Date:  1982-08       Impact factor: 5.662

6.  Location and activity of ulcerative and Crohn's colitis by indium 111 leukocyte scan. A prospective comparison study.

Authors:  D T Stein; G M Gray; P B Gregory; M Anderson; D A Goodwin; I R McDougall
Journal:  Gastroenterology       Date:  1983-02       Impact factor: 22.682

7.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

8.  Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion.

Authors:  S H Saverymuttu; M Camilleri; H Rees; J P Lavender; H J Hodgson; V S Chadwick
Journal:  Gastroenterology       Date:  1986-05       Impact factor: 22.682

9.  The effects of polycations on vascular permeability in the rat. A proposed role for charge sites.

Authors:  V M Vehaskari; C T Chang; J K Stevens; A M Robson
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

10.  Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion.

Authors:  Y S Kanwar; A Linker; M G Farquhar
Journal:  J Cell Biol       Date:  1980-08       Impact factor: 10.539

View more
  12 in total

1.  CD4 T cells are required for both development and maintenance of disease in a new mouse model of reversible colitis.

Authors:  J Brasseit; E Althaus-Steiner; M Faderl; N Dickgreber; L Saurer; V Genitsch; T Dolowschiak; H Li; D Finke; W-D Hardt; K D McCoy; A J Macpherson; N Corazza; M Noti; C Mueller
Journal:  Mucosal Immunol       Date:  2015-09-16       Impact factor: 7.313

2.  Effects of free radicals and leukocytes on increases in blood-brain barrier permeability during colitis.

Authors:  C A Hathaway; W H Percy; J L Williams
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

3.  Inflammatory Bowel Diseases Are Associated With an Increased Risk for Chronic Kidney Disease, Which Decreases With Age.

Authors:  Ravy K Vajravelu; Lawrence Copelovitch; Mark T Osterman; Frank I Scott; Ronac Mamtani; James D Lewis; Michelle R Denburg
Journal:  Clin Gastroenterol Hepatol       Date:  2019-11-01       Impact factor: 11.382

4.  Soluble adhesion molecules in inflammatory bowel disease.

Authors:  M G Goggins; J Goh; M A O'Connell; D G Weir; D Kelleher; N Mahmud
Journal:  Ir J Med Sci       Date:  2001 Apr-Jun       Impact factor: 1.568

Review 5.  Histologic scoring indices for evaluation of disease activity in ulcerative colitis.

Authors:  Mahmoud H Mosli; Claire E Parker; Sigrid A Nelson; Kenneth A Baker; John K MacDonald; G Y Zou; Brian G Feagan; Reena Khanna; Barrett G Levesque; Vipul Jairath
Journal:  Cochrane Database Syst Rev       Date:  2017-05-25

6.  Measuring differences between patients' and physicians' health perceptions: the patient-physician discordance scale.

Authors:  Maida J Sewitch; Michal Abrahamowicz; Patricia L Dobkin; Robyn Tamblyn
Journal:  J Behav Med       Date:  2003-06

7.  Decay-accelerating factor (DAF) in stool specimens as a marker of disease activity in patients with ulcerative colitis (UC).

Authors:  T Inaba; M Mizuno; S Ohya; M Kawada; T Uesu; J Nasu; K Takeuchi; M Nakagawa; H Okada; T Fujita; T Tsuji
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

8.  Microproteinuria in patients with inflammatory bowel disease: is it associated with the disease activity or the treatment with 5-aminosalicylic acid?

Authors:  Androniki C Poulou; Konstantinos E Goumas; Dimitrios C Dandakis; Ioannis Tyrmpas; Maria Panagiotaki; Androniki Georgouli; Dimitrios C Soutos; Athanasios Archimandritis
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

9.  No dose-dependent tubulotoxicity of 5-aminosalicylic acid: a prospective study in patients with inflammatory bowel diseases.

Authors:  Carsten Dehmer; Roland Greinwald; Juergen Löffler; Wolfgang Grotz; Lothar Wolf; Hans-Burkhardt Hagmann; Werner Schneider; Wolfgang Kreisel
Journal:  Int J Colorectal Dis       Date:  2003-02-08       Impact factor: 2.571

Review 10.  Identification and management of albuminuria in the primary care setting.

Authors:  Louis Kuritzky; Robert Toto; Peter Van Buren
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-02-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.